Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Provision of Pathology Testing Services

Queen Victoria Hospital NHS Foundation Trust · planning

Tender information last checkedLast checked 8 Oct 2026, 20:36.

Opportunity overview

This is a Provider Selection Regime (PSR) intention to award notice. Provision of Pathology testing services

Classification

  • CPV85111800 — Pathology services

Lots

  • Content of notice of intention to award to the existing provider under Direct Award Process C<br/><br/>1. A statement that the relevant authority is intending to award a contract to an existing provider following Direct Award Process C.<br/><br/>This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 19/10/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR<br/><br/><br/>2.The contract title and reference.<br/><br/>Title: Provision of Pathology Testing Services<br/><br/>3.The name and address of the registered office or principal place of business of the provider to whom an award is to be made.<br/><br/>Synnovis Analytics LLP<br/>Friars Bridge Court, 41-43 Blackfriars Road, London, England, SE1 8NZ<br/><br/>4.A description of the relevant health care services to which the contract relates, including the most relevant CPV code<br/><br/>Description – Pathology services<br/>CPV Code – 85111800– Pathology services<br/><br/>5.The approximate lifetime value of the contract.<br/><br/>£130,000 (24 months)<br/><br/><br/><br/>6.Details of the award decision-makers.<br/><br/>Key Individuals – Queen Victoria Hospital NHS Foundation Trust<br/><br/>Head of Pathology<br/><br/><br/>7.A statement explaining the award decision-makers’ reasons for selecting the chosen provider<br/>1. Quality and Innovation – Existing supplier for pathology testing. No issues with current supply,<br/>2. Value – They have consistently over a period of time delivered a valuable service within the available budget allocation.<br/><br/><br/>8.Any declared conflicts or potential conflicts of interest.<br/><br/><br/>None declared<br/><br/>9.Information as to how any conflicts or potential conflicts of interest were managed.<br/><br/>N/AValue not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
C475768
Status
planned
Main Procurement Category
services

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Scheme
CPV
Id
85111800
Description
Pathology services

Communication

Future Notice Date
20 Oct 2026, 00:00

Lots and requirements

Entry 1
Id
1
Description
Content of notice of intention to award to the existing provider under Direct Award Process C<br/><br/>1. A statement that the relevant authority is intending to award a contract to an existing provider following Direct Award Process C.<br/><br/>This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 19/10/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR<br/><br/><br/>2.The contract title and reference.<br/><br/>Title: Provision of Pathology Testing Services<br/><br/>3.The name and address of the registered office or principal place of business of the provider to whom an award is to be made.<br/><br/>Synnovis Analytics LLP<br/>Friars Bridge Court, 41-43 Blackfriars Road, London, England, SE1 8NZ<br/><br/>4.A description of the relevant health care services to which the contract relates, including the most relevant CPV code<br/><br/>Description – Pathology services<br/>CPV Code – 85111800– Pathology services<br/><br/>5.The approximate lifetime value of the contract.<br/><br/>£130,000 (24 months)<br/><br/><br/><br/>6.Details of the award decision-makers.<br/><br/>Key Individuals – Queen Victoria Hospital NHS Foundation Trust<br/><br/>Head of Pathology<br/><br/><br/>7.A statement explaining the award decision-makers’ reasons for selecting the chosen provider<br/>1. Quality and Innovation – Existing supplier for pathology testing. No issues with current supply,<br/>2. Value – They have consistently over a period of time delivered a valuable service within the available budget allocation.<br/><br/><br/>8.Any declared conflicts or potential conflicts of interest.<br/><br/><br/>None declared<br/><br/>9.Information as to how any conflicts or potential conflicts of interest were managed.<br/><br/>N/A
Status
planned

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKJ2

Buyer, suppliers and contacts

Organisation 1
Name
Queen Victoria Hospital NHS Foundation Trust
Id
GB-FTS-17423

Identifier

Legal Name
Queen Victoria Hospital NHS Foundation Trust

Address

Street Address
Holtye Road
Locality
East Grinstead
Region
UKJ2
Postal Code
RH19 3DZ
Country Name
United Kingdom

Contact

Name
Charles Kirabo (QVH)

Roles

buyer

Details

Classifications

Entry 1
Scheme
TED_CA_TYPE
Id
BODY_PUBLIC
Description
Body governed by public law
Entry 2
Scheme
COFOG
Id
07
Description
Health

Recorded locations

  • Buyer location · East Grinstead · UKJ2 · RH19 3DZ · United Kingdom
  • Delivery location · UKJ2

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. 095434-2026planning ·

PROCURAAXIS ANALYSIS

ProcuraAxis Analysis

Our approved analysis of the opportunity appears below the official tender information.

ANALYSIS PREVIEW

Opportunity intelligence at a glance

Early-stage/planned PSR intention-to-award notice for pathology testing services. Queen Victoria Hospital NHS Foundation Trust intends to award a 24-month, approximately £130,000 contract to its existing provider, Synnovis Analytics LLP, using Direct Award Process C. This is not an open bidding opportunity; the notice starts a standstill period during which providers may make representations by 19 October 2026.

Who this may suit

Not a competitive supplier opportunity as published: the authority identifies an existing intended provider and a direct-award route. Other providers may make representations during the stated standstill period.

Key points identified

  • Service requirementProvision of pathology testing servicesEvidence: Notice title: "Provision of Pathology Testing Services"; lot description: "Description – Pathology services".
  • Named intended providerSynnovis Analytics LLPEvidence: Lot description identifies "the provider to whom an award is to be made" as Synnovis Analytics LLP.
  • Supplier eligibility requirementsUnknownEvidence: No selection, exclusion, financial, technical, insurance, certification or accreditation requirements are stated in the supplied notice.
98% approved-analysis confidence3 supplier criteria identified3 risks or unknowns

SOURCE AND FRESHNESS

Traceable procurement data

Source
Find a Tender
Notice reference
095434-2026
OCID
ocds-h6vhtk-07843f
First published
8 Oct 2026
Last checked
8 Oct 2026, 20:36
Notice versions reviewed
1

HOW THIS WAS PREPARED

Approved, evidence-bound analysis

ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.

Analysis status
Approved for publication
Analysed
8 Oct 2026
Read the analysis methodology →